X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare JUBILANT LIFE SCIENCES with TTK HEALTHCARE - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

JUBILANT LIFE SCIENCES vs TTK HEALTHCARE - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    JUBILANT LIFE SCIENCES TTK HEALTHCARE JUBILANT LIFE SCIENCES/
TTK HEALTHCARE
 
P/E (TTM) x 19.9 28.4 70.2% View Chart
P/BV x 4.2 5.2 81.0% View Chart
Dividend Yield % 0.4 0.6 77.2%  

Financials

 JUBILANT LIFE SCIENCES   TTK HEALTHCARE
EQUITY SHARE DATA
    JUBILANT LIFE SCIENCES
Mar-14
TTK HEALTHCARE
Mar-14
JUBILANT LIFE SCIENCES/
TTK HEALTHCARE
5-Yr Chart
Click to enlarge
High Rs187663 28.2%   
Low Rs65399 16.3%   
Sales per share (Unadj.) Rs364.3535.6 68.0%  
Earnings per share (Unadj.) Rs6.815.9 42.9%  
Cash flow per share (Unadj.) Rs24.520.0 122.3%  
Dividends per share (Unadj.) Rs3.004.00 75.0%  
Dividend yield (eoy) %2.40.8 316.3%  
Book value per share (Unadj.) Rs164.9137.6 119.8%  
Shares outstanding (eoy) m159.287.77 2,049.9%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.31.0 34.9%   
Avg P/E ratio x18.433.3 55.2%  
P/CF ratio (eoy) x5.126.5 19.4%  
Price / Book Value ratio x0.83.9 19.8%  
Dividend payout %43.825.1 174.7%   
Avg Mkt Cap Rs m20,0614,127 486.0%   
No. of employees `0006.21.7 362.1%   
Total wages/salary Rs m11,052607 1,821.9%   
Avg. sales/employee Rs Th9,383.02,436.7 385.1%   
Avg. wages/employee Rs Th1,786.9355.2 503.1%   
Avg. net profit/employee Rs Th176.372.5 243.0%   
INCOME DATA
Net Sales Rs m58,0344,162 1,394.4%  
Other income Rs m19161 311.4%   
Total revenues Rs m58,2244,223 1,378.7%   
Gross profit Rs m5,786197 2,935.7%  
Depreciation Rs m2,81232 8,869.7%   
Interest Rs m3,23730 10,826.8%   
Profit before tax Rs m-72197 -36.7%   
Minority Interest Rs m-2860-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m2,1450-   
Tax Rs m69673 956.6%   
Profit after tax Rs m1,090124 880.1%  
Gross profit margin %10.04.7 210.5%  
Effective tax rate %-965.937.0 -2,609.7%   
Net profit margin %1.93.0 63.1%  
BALANCE SHEET DATA
Current assets Rs m29,2801,629 1,797.8%   
Current liabilities Rs m38,9121,058 3,678.5%   
Net working cap to sales %-16.613.7 -121.0%  
Current ratio x0.81.5 48.9%  
Inventory Days Days8430 283.4%  
Debtors Days Days5134 150.9%  
Net fixed assets Rs m55,712556 10,014.7%   
Share capital Rs m15578 198.8%   
"Free" reserves Rs m20,968878 2,387.3%   
Net worth Rs m26,2651,069 2,456.3%   
Long term debt Rs m17,169159 10,818.4%   
Total assets Rs m88,6062,399 3,692.8%  
Interest coverage x1.07.6 12.9%   
Debt to equity ratio x0.70.1 440.4%  
Sales to assets ratio x0.71.7 37.8%   
Return on assets %4.96.4 76.2%  
Return on equity %4.211.6 35.8%  
Return on capital %11.618.5 62.7%  
Exports to sales %37.80.8 4,780.8%   
Imports to sales %16.51.4 1,176.9%   
Exports (fob) Rs m21,93333 66,664.7%   
Imports (cif) Rs m9,56758 16,410.5%   
Fx inflow Rs m22,00433 66,881.8%   
Fx outflow Rs m11,74963 18,593.0%   
Net fx Rs m10,255-30 -33,856.7%   
CASH FLOW
From Operations Rs m8,026127 6,339.7%  
From Investments Rs m-1,744-146 1,194.7%  
From Financial Activity Rs m-4,44722 -20,307.8%  
Net Cashflow Rs m1,8343 73,378.0%  

Share Holding

Indian Promoters % 45.6 65.4 69.7%  
Foreign collaborators % 3.5 0.0 -  
Indian inst/Mut Fund % 8.7 3.7 235.1%  
FIIs % 21.2 5.2 407.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 21.1 25.8 81.8%  
Shareholders   23,815 12,723 187.2%  
Pledged promoter(s) holding % 15.9 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare JUBILANT LIFE SCIENCES With:   SUVEN LIFE  SHASUN PHARMA  PFIZER  FDC LTD.  SUN PHARMA  

Compare JUBILANT LIFE SCIENCES With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Strong Note; Tata Global Beverages Surges 8.3%(Closing)

Indian share markets snapped their losing streak of last week and finished the trading day on a strong note due to strong buying momentum in FMCG stocks, metal stocks and auto stocks.

Related Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

JUBILANT LIFE SCIENCES SHARE PRICE


Aug 16, 2017 (Close)

TRACK JUBILANT LIFE SCIENCES

  • Track your investment in JUBILANT LIFE SCIENCES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON JUBILANT LIFE SCIENCES

JUBILANT LIFE SCIENCES 5-YR ANALYSIS

COMPARE JUBILANT LIFE SCIENCES WITH

MARKET STATS